CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
Catena Pharmaceuticals is focused on the development and commercialization of GPCR antagonists, particularly in the areas of cancer and fibrotic disease. Catena's chemistry is capable of affecting a specific class of GPCRs known to be relevant in a...Show all
Company (Alive / Active)
Phone: 888-265-1353
2530 Meridian Parkway
Suite 200
Durham, 27713
North Carolina, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Catena Pharmaceuticals | $0M | Oct 20, 2008 |
| See all 16 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Name | Firm |
|---|---|
| Login to see details | Golden Pine Ventures |
| Company | Status | Description | Investors |
|---|---|---|---|
| Vancouver, British Columbia, Canada | Alive / Active | Inimex Pharmaceuticals, Inc. is focused on the development and commercialization of Innate Defense Regulators (IDRs), first in class drugs that selectively trigger the body's innate defenses without causing inflammation. IDR products have major market potential for infectious disease, cancer, and inflammatory disease. These products will reduce morbidity and mortality in the rapidly growing population of immune suppressed and elderly patients who are "at-risk" for these disorders. IDR produc...Show all | Login to see details |
| Cambridge, Massachusetts, United States | IPO / Went public | Akebia Therapeutics is focused on discovering and developing therapeutic solutions leveraging the potential of the hypoxia-inducible factor - or HIF - biology. HIF-Prolyl Hydroxylase inhibition could represent an approach to treating certain conditions where there is an unmet need. | Login to see details |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|
